Medical Weight Loss for Holland, Michigan Residents
Holland, Michigan residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Physician-supervised GLP-1 programs from $166/month · just $5.50/day, serving Holland through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.
Why Holland Residents Choose New Hope Weight Loss
Holland patients choose New Hope Weight Loss because a named physician, Dr. Anjmun Sharma, M.D., oversees every case, pricing is transparent (semaglutide from $166/month, tirzepatide from $233/month · just $7.70/day), and the entire program runs by telehealth from our Costa Mesa, California clinic, which has served over 5,400 patients across Michigan and beyond since 2020.
Holland residents do not need a local clinic to start. Our physician-led program is delivered by secure video from Costa Mesa, California, with flat nationwide pricing and compounded medication mailed in cold-pack packaging to your Holland address.
In Holland, Michigan, you do not need a local clinic to begin: our physician-led program reaches you by telehealth. We care for patients throughout downtown Holland and the Lake Michigan shore of Ottawa County. There is no distance surcharge for Holland patients, and HSA, FSA, Klarna, and Affirm are all accepted.
For Holland residents, being seen by video means starting this week instead of waiting for an in-person appointment. Compounded semaglutide and tirzepatide are not FDA-approved or brand-identical, which Dr. Sharma reviews with you before you begin.
GLP-1 Weight Loss Programs Available
Compounded semaglutide, from $166/mo (90-day program $499)
The 90-day Metabolic Reset is our most-chosen plan. Semaglutide shares its active ingredient with Wegovy® and Ozempic®; in trials of the branded drug, patients lost an average of 15-17% of body weight under physician supervision.
Compounded tirzepatide, from $233/mo
Tirzepatide's dual GLP-1/GIP action reached up to 22.5% body-weight loss in trials of the branded medication, the advanced option for Holland patients.
The physician review is a flat $119, with medication billed separately; HSA, FSA, Klarna, and Affirm are accepted.
How Telehealth Works for Holland
1. Tell us your history through the quiz or intake form. 2. Dr. Sharma confirms your eligibility by secure video, usually within 48 hours. 3. Your compounded medication arrives at your Holland address in cold-pack packaging, with ongoing follow-up from the team, all without leaving home.
Frequently Asked Questions, Holland
Does New Hope Weight Loss treat patients in Holland?
Yes. Although the clinic is in Costa Mesa, California, we treat Holland, Michigan residents by telehealth, Dr. Sharma reviews your case by secure video and compounded medication ships to your home. Eligibility is confirmed during the consultation.
Do I have to travel to get started from Holland?
No travel is needed. The whole process, intake, consultation, and follow-ups, is by secure video, and your medication arrives at your Holland address in cold-pack packaging.
What do Holland patients pay?
Flat nationwide pricing: $119 for the physician review, then semaglutide from $166/month and tirzepatide from $233/month, medication billed separately. HSA, FSA, Klarna, and Affirm are accepted, with no distance surcharge.
What areas of Holland do you serve?
We serve patients from across Holland by telehealth, including downtown Holland and the Lake Michigan shore of Ottawa County.
Are there hidden fees for Holland patients?
No. Holland patients pay the same flat, stated pricing: a $119 physician visit, then compounded semaglutide from $166/month or tirzepatide from $233/month with medication billed separately. There is no membership lock-in and no distance surcharge.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Holland, Michigan by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.